selected publications 3

Articles (*Peer Reviewed)
In English:

* 34. Aktan H, Paykoc Z, Ertan A: Ulcerative colitis -problem in Turkey. The Proceedings of the 3rd. World Congress of Gastroenterology, 2:514-517, 1966.

* 35. Aktan H, Paykoc Z, Ertan A: Ulcerative colitis in Turkey. Dis Col and Rect, 13:62-65, 1970.

* 36. Ertan A, Brooks FP, Ostrow JD, et al: Effect of jejunal amino acid perfusion and exogenous cholecystokinin on the exocrine pancreatic and biliary secretions in man. Gastroenterology, 61:686-692, 1971.

* 37. Lanciault G, Ertan A, Adair LS, Brooks FP: Effect of endogenous cholecystokinin on gastrin release in man and dog. Digestion, 10:228-230, 1974.

* 38. Ertan A, Brooks FP, Arvan D, Williams CN: Mechanism of release of endogenous cholecystokinin by jejunal amino acid perfusion in man. Amer J Dig Dis, 20:813-823, 1975.

* 39. Lanciault G, Ertan A, Adair LS, Brooks FP; The effect of cholecystokinin pancreozymin on circulating gastrin levels in man and dog. Amer J Dig Dis, 21:39-43, 1976.

* 40. Nelson EW, Ertan A, Brooks FP, Cerda JJ: Thrombocytosis in patients with celiac sprue. Gastroenterology, 70:1042-1045, 1976.

* 41. Paykoc Z, Sumer N, Ertan A, Akit A: Effect of colchicine on serum cAMP values in familial Mediterranean fever. VI World Congress of Gastroenterology, 1:21-22, 1978.

* 42. Ertan A, Kandilci U, Danisoglu V, Aktan H, Paykoc Z: Diagnostic values of endoscopic retrograde cholangiography and Chiba percutaneous transhepatic cholangiography in patients with postcholecystectomy syndrome. VI World Congress of Gastroenterology, 1:109-110, 1978.

* 43. Paykoc Z, Sumer N, Ertan A, Akit A: Plasma cyclic nucleotide in FMF patients with effect of colchicine. New Engl J Med 300:1160-1161, 1979.

* 44. Ertan A, Kandilci U, Danisoglu V, et al: A comparison of percutaneous transhepatic cholangiography and endoscopic retrograde cholangiopancreatography in postcholecystectomy jaundice. J Clin Gastroenterol, 3:67-72, 1981.

* 45. Ertan A, Taminato T, Akdamar K, et al: Immunoreactive somatostatin in human pancreatic secretion. J Clin Endocrinol Metab 52:589-591, 1981.

* 46. Arimura A, Groot K, Taminato T, Ertan A, et al: Somatostatin in human pancreatic and gastric juice. Peptides, The Brain-Gut Axis: A New Frontier. Supp I:271-274, 1981.

* 47. Ertan A, Acikalin T, Akdamar K: Prepyloric diverticulum. Gastrointest Endosc 28:46-48, 1982.

* 48. McMahon FG, Ryan JR, Akdamar K, Ertan A: Upper gastrointestinal lesions after potassium chloride supplements: A controlled clinical trial. Lancet II: 1059-1061, 1982.

* 49. Akdamar K, Agrawal NM, Ertan A: Inhibition of nocturnal gastric secretion in normal volunteers by misoprostol, a synthetic prostaglandin E1 methyl ester analog. Amer J Gastroenterol 77:902-904, 1982.

* 50. Ertan A, Kedia SM, Agrawal NM, Akdamar K: Fiberendoscopic removal of a tooth-brush from the gastro duodenal area using a rat tooth forceps. Gastrointest Endosc 29:144-145, 1983 (LTE).

* 51. Gordon K, Ertan A, Janney A, et al: Campylobacter enterocolitis in New Orleans. J Southern Med Assoc 76:855-858, 1983.

* 52. Ertan A, Sahin B, Kandilci U, et al: The mechanism of cholestasis secondary to hepatic hydatid cysts. J Clin Gastroenterol, 5:437-440, 1983.

* 53. Ryan JR, McMahon FG, Akdamar, K, Ertan A, Agrawal N: Mucosal irritant potential of a potassium-sparing diuretic and of wax-matrix potassium chloride. J Clin Pharmacol Ther, 35:90-93, 1984.

* 54. Ertan A, Arimura A, Akdamar K, et al: Pancreatic immunoreactive somatostatin and diabetes mellitus. Dig Dis Sci 29:625-630, 1984.